Dianthus Therapeutics 320% Year: What Investors Should Know as Stakes Shift
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Ryanair stock moved higher after better-than-expected Q4 results and improving profitability. This article breaks dow...
An inherited IRA can be a powerful retirement tool, but mishandling it costs you. This guide reveals the biggest miss...
A standout move in the world of investing: a wealth manager makes a sizable bet on an active international rotation E...
When a stock stalls, a disciplined fund can still see value in the long run. This article explains why this fund made...
Last year, a notable fintech stock faced a sharp decline. A major fund then exited a $4 million stake, signaling a sh...
A major hedge fund just disclosed a multi-million stake in Crinetics, a rare-disease biotech. This article unpacks wh...
The Vatican has established a dedicated AI commission as Pope Leo XIV prepares a papal encyclical on AI ethics with A...
NuScale Power just reported earnings, and the market pushed the stock lower. This article explains why patient invest...
A major hedge fund just plowed a substantial stake into a gene-editing company, signaling conviction in Beam Therapeu...
Nvidia stock investors just received a wave of bullish commentary from analysts as AI demand powers data centers and ...
A major hedge fund just placed a multi-million bet on a biotech company after FDA approval. This article breaks down ...